Vesicoureteral reflux (VUR) potentially leads to renal damage, scarring, and eventually end-stage renal disease. Endoscopic treatment is well tolerated in children, it has reduced costs, and it effectively prevents urinary tract infections (UTIs), while avoiding long term antibiotics use.
Zambaiti, E., Sergio, M., Di Pace, M., Casuccio, A., & Cimador, M. (2020). The fate of implant after endoscopic injection of dextranomer/hyaluronic acid in vesicoureteral reflux: time to partial reabsorption and stabilization. JOURNAL OF PEDIATRIC UROLOGY.
Data di pubblicazione: | 2020 |
Titolo: | The fate of implant after endoscopic injection of dextranomer/hyaluronic acid in vesicoureteral reflux: time to partial reabsorption and stabilization |
Autori: | |
Citazione: | Zambaiti, E., Sergio, M., Di Pace, M., Casuccio, A., & Cimador, M. (2020). The fate of implant after endoscopic injection of dextranomer/hyaluronic acid in vesicoureteral reflux: time to partial reabsorption and stabilization. JOURNAL OF PEDIATRIC UROLOGY. |
Rivista: | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.jpurol.2019.12.010 |
Abstract: | Vesicoureteral reflux (VUR) potentially leads to renal damage, scarring, and eventually end-stage renal disease. Endoscopic treatment is well tolerated in children, it has reduced costs, and it effectively prevents urinary tract infections (UTIs), while avoiding long term antibiotics use. |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
fate of implant.pdf | Pre-print | Administrator Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.